| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |